有机硫化合物是指含有硫原子的有机化合物。这些化合物在自然界中广泛存在,在医药、农药和材料科学等领域有着重要的应用。有机硫化合物因其化学性质独特,在药物设计、合成化学以及材料制备方面扮演着重要角色。
1. 结构与分类有机硫化合物可以按硫的连接方式分为饱和和不饱和类,如二硫化物、噻吩衍生物、砜等。常见的结构类型有:
许多有机硫化合物在生物学上有重要功能或应用潜力。例如:
有机硫化合物可通过多种途径合成:
有机硫化合物的应用广泛:
尽管有机硫化合物具有许多潜在益处,但其生产和使用也可能对环境造成影响。因此,在设计和合成这些化合物时需要考虑可持续性和环保性因素。
以上是对有机硫化合物的简单介绍,包括它们的结构、生物学活性、合成方法及其应用领域等基本信息。
中文名称 | 英文名称 | CAS号 | 化学式 | 结构式图片 |
---|---|---|---|---|
—— | 2-[(3,5-Difluorophenyl)methylsulfanyl]-6-ethyl-3-methyl-5-[(3-methylphenyl)methyl]pyrimidin-4-one | —— | C22H22F2N2OS |
|
—— | N'-[2-[1-[[(2S)-oxolan-2-yl]methyl]tetrazol-5-yl]sulfanylacetyl]cyclobutanecarbohydrazide | —— | C13H20N6O3S |
|
—— | (3R)-3-(4-fluorophenyl)sulfanyl-1-(2,2,2-trifluoroethyl)pyrrolidin-2-one | —— | C12H11F4NOS |
|
—— | 2-[[(2R)-oxan-2-yl]methylsulfanyl]-1-propan-2-ylpyrimidin-4-one | —— | C13H20N2O2S |
|
—— | 2-[[(2S)-oxan-2-yl]methylsulfanyl]-1-propan-2-ylpyrimidin-4-one | —— | C13H20N2O2S |
|
—— | (3S)-3-(4-fluorophenyl)sulfanyl-1-(2,2,2-trifluoroethyl)pyrrolidin-2-one | —— | C12H11F4NOS |
|
—— | N'-[2-[1-[[(2R)-oxolan-2-yl]methyl]tetrazol-5-yl]sulfanylacetyl]cyclobutanecarbohydrazide | —— | C13H20N6O3S |
|
—— | 2-[(2S)-oxolan-2-yl]-N-[4-(1,3,4-thiadiazol-2-ylsulfanyl)phenyl]acetamide | —— | C14H15N3O2S2 |
|
—— | N,N-diethyl-2-(1,4,5-trimethyl-6-oxopyrimidin-2-yl)sulfanylacetamide | —— | C13H21N3O2S |
|
—— | 2-[5-benzyl-4-(methoxymethyl)-1-methyl-6-oxopyrimidin-2-yl]sulfanyl-N-[(2S)-3-methylbutan-2-yl]acetamide | —— | C21H29N3O3S |
|
—— | methyl (3S)-3-(4-methylsulfanylphenyl)-3-(pyridin-3-ylcarbamoylamino)propanoate | —— | C17H19N3O3S |
|
—— | 2-[(2,6-Difluorophenyl)methylsulfanyl]-6-ethyl-3-methyl-5-[(3-methylphenyl)methyl]pyrimidin-4-one | —— | C22H22F2N2OS |
|
—— | 2-[(2R)-oxolan-2-yl]-N-[4-(1,3,4-thiadiazol-2-ylsulfanyl)phenyl]acetamide | —— | C14H15N3O2S2 |
|
—— | 2-[5-benzyl-4-(methoxymethyl)-1-methyl-6-oxopyrimidin-2-yl]sulfanyl-N-[(2R)-3-methylbutan-2-yl]acetamide | —— | C21H29N3O3S |
|
—— | methyl (3R)-3-(4-methylsulfanylphenyl)-3-(pyridin-3-ylcarbamoylamino)propanoate | —— | C17H19N3O3S |
|
—— | (2R)-2-(3-methylbutoxy)-N-[2-[(4-methyl-1,2,4-triazol-3-yl)sulfanyl]phenyl]propanamide | —— | C17H24N4O2S |
|
—— | 3-chloro-2-[[(4S)-1,3-dioxan-4-yl]methylsulfanyl]pyridine | —— | C10H12ClNO2S |
|
—— | 3-chloro-2-[[(4R)-1,3-dioxan-4-yl]methylsulfanyl]pyridine | —— | C10H12ClNO2S |
|
—— | Methyl 2-(1,4-dimethyl-6-oxopyrimidin-2-yl)sulfanylacetate | —— | C9H12N2O3S |
|
—— | 3-[[(1S)-1-cyclopropylethyl]-[(5-methylsulfanyl-2-sulfanylidene-1,3,4-thiadiazol-3-yl)methyl]amino]propanenitrile | —— | C12H18N4S3 |
|
—— | N-[(2S)-2-cyano-3-methylbutan-2-yl]-2-[[5-(dimethylamino)-4-propan-2-yl-1,2,4-triazol-3-yl]sulfanyl]acetamide | —— | C15H26N6OS |
|
—— | [(1S)-1-[5-(2-amino-2-oxoethyl)sulfanyl-1,3,4-oxadiazol-2-yl]-3-methylbutyl]azanium | —— | C9H17N4O2S+ |
|
—— | 3-[[(1R)-1-cyclopropylethyl]-[(5-methylsulfanyl-2-sulfanylidene-1,3,4-thiadiazol-3-yl)methyl]amino]propanenitrile | —— | C12H18N4S3 |
|
—— | [(1S,2R)-2-methyl-1-[5-[(4-methylphenyl)methylsulfanyl]-1,3,4-oxadiazol-2-yl]butyl]azanium | —— | C15H22N3OS+ |
|
—— | methyl (3S)-3-(cyclopropylcarbamoylamino)-3-(4-methylsulfanylphenyl)propanoate | —— | C15H20N2O3S |
|
—— | methyl (3R)-3-(cyclopropylcarbamoylamino)-3-(4-methylsulfanylphenyl)propanoate | —— | C15H20N2O3S |
|
—— | [(1S)-1-[5-[(3-methylphenyl)methylsulfanyl]-1,3,4-oxadiazol-2-yl]ethyl]azanium | —— | C12H16N3OS+ |
|
—— | [(1S,2R)-1-[5-[(4-chlorophenyl)methylsulfanyl]-1,3,4-oxadiazol-2-yl]-2-methylbutyl]azanium | —— | C14H19ClN3OS+ |
|
—— | [(1S)-1-[5-[(2,5-dimethylphenyl)methylsulfanyl]-1,3,4-oxadiazol-2-yl]-3-methylbutyl]azanium | —— | C16H24N3OS+ |
|
—— | 2-[[5-[2-oxo-2-[(2S)-2-thiophen-2-ylpyrrolidin-1-yl]ethyl]sulfanyl-1,3,4-thiadiazol-2-yl]sulfanyl]-N-propylacetamide | —— | C17H22N4O2S4 |
|
—— | 2-[[5-[2-oxo-2-[(2R)-2-thiophen-2-ylpyrrolidin-1-yl]ethyl]sulfanyl-1,3,4-thiadiazol-2-yl]sulfanyl]-N-propylacetamide | —— | C17H22N4O2S4 |
|
—— | 1-Ethyl-4-[2-(4-methylphenyl)sulfanylethyl]piperazine-1,4-diium | —— | C15H26N2S+2 |
|
—— | N-[2-(4-fluorophenyl)ethyl]-2-(2-methylphenyl)sulfanylacetamide | —— | C17H18FNOS |
|
—— | 2-ethyl-5-[(1S)-1-(4-methylphenyl)sulfanylethyl]-1,3,4-oxadiazole | —— | C13H16N2OS |
|
—— | 2-[[(5R)-2-morpholin-4-yl-4,5-dihydro-1,3-thiazol-5-yl]methylsulfanyl]pyridine-4-carbonitrile | —— | C14H16N4OS2 |
|
—— | (1R)-1-(4-bromophenyl)-2-[(4-propan-2-yl-1,2,4-triazol-3-yl)sulfanyl]ethanol | —— | C13H16BrN3OS |
|
—— | 5-[(1S)-1-(3-chlorophenyl)sulfanylethyl]-3-methyl-1,2,4-oxadiazole | —— | C11H11ClN2OS |
|
—— | 2-[[(5S)-2-morpholin-4-yl-4,5-dihydro-1,3-thiazol-5-yl]methylsulfanyl]pyridine-4-carbonitrile | —— | C14H16N4OS2 |
|
—— | 4-cyclopropyl-3-[(1S)-2,2,2-trifluoro-1-phenylethyl]sulfanyl-1,2,4-triazole | —— | C13H12F3N3S |
|
—— | (1S)-1-(4-bromophenyl)-2-[(4-propan-2-yl-1,2,4-triazol-3-yl)sulfanyl]ethanol | —— | C13H16BrN3OS |
|
—— | 2-ethyl-5-[(1R)-1-(4-methylphenyl)sulfanylethyl]-1,3,4-oxadiazole | —— | C13H16N2OS |
|
—— | 5-[(1R)-1-(3-chlorophenyl)sulfanylethyl]-3-methyl-1,2,4-oxadiazole | —— | C11H11ClN2OS |
|
—— | 4-cyclopropyl-3-[(1R)-2,2,2-trifluoro-1-phenylethyl]sulfanyl-1,2,4-triazole | —— | C13H12F3N3S |
|
—— | 2-(3-chlorophenyl)sulfanyl-N-[(3R)-1,1-dioxothiolan-3-yl]acetamide | —— | C12H14ClNO3S2 |
|
—— | methyl (2R)-2-phenyl-2-[4-(trifluoromethyl)pyrimidin-2-yl]sulfanylacetate | —— | C14H11F3N2O2S |
|
—— | 2-(3-chlorophenyl)sulfanyl-N-[(3S)-1,1-dioxothiolan-3-yl]acetamide | —— | C12H14ClNO3S2 |
|
—— | methyl (2S)-2-phenyl-2-[4-(trifluoromethyl)pyrimidin-2-yl]sulfanylacetate | —— | C14H11F3N2O2S |
|
—— | methyl (2S)-2-[(4-methyl-5-thiophen-2-yl-1,2,4-triazol-3-yl)sulfanyl]-2-phenylacetate | —— | C16H15N3O2S2 |
|
—— | 1-(5-chlorothiophen-2-yl)-2-[[(1S,8R)-8,11,11-trimethyl-3,4,6-triazatricyclo[6.2.1.02,7]undeca-2(7),3,5-trien-5-yl]sulfanyl]ethanone | —— | C17H18ClN3OS2 |
|
—— | 4-cyclohexyl-3-[[(4S)-1,3-dioxan-4-yl]methylsulfanyl]-5-(furan-2-yl)-1,2,4-triazole | —— | C17H23N3O3S |
|